Canada faces prolonged economic uncertainty with slow growth, inflation, and workforce shortages. Yet one major driver of lost productivity remains largely absent from the national debate: cancer. The disease costs Canada $37.7 billion annually and is projected to rise 23% by 2034.
Cancer is Canada’s leading cause of death. Deaths are expected to increase 44% between 2020 and 2040. Younger adults are increasingly affected, with colorectal cancer rates in this group 2 to 2.5 times higher than previous generations. Progress against cervical cancer has stalled, and access to screening remains uneven across regions.
Economic Toll of Cancer in Canada
Cancer’s impact extends beyond health. It strains provincial budgets, reduces workplace productivity, and disrupts families. In 2024, the disease cost Canada $37.7 billion—a figure projected to rise 23% over the next decade. These costs include lost wages, reduced productivity, and caregiver burnout. For households, 2 in 5 cancer patients report that out-of-pocket costs hinder retirement savings.
Canada’s healthcare system, which supports nearly 2 million workers and contributes 8% of GDP, is a significant economic driver. Strengthening cancer care could bolster the economy, yet governments often treat it as a cost to contain rather than an investment in growth.
Prevention and Early Detection: A Powerful Tool
Four in 10 cancers are preventable, and early detection saves lives while reducing treatment complexity. However, Canada often pays more for late-stage treatments due to insufficient investment in early-stage solutions. With more young Canadians diagnosed with cancer, failing to address this will undermine labor force development and long-term competitiveness.
The upcoming Canada Health Transfer negotiations present an opportunity to rethink cancer’s impact on the economy. A 1% annual increase in funding, about $575 million per year, could modernize prevention, screening, diagnosis, and treatment nationwide. Targeted funding ensures resources directly improve cancer outcomes.
Investing in Cancer Care: A Dual Benefit
Investing in cancer care yields both human and economic benefits. It prevents more cancers, detects them early, and improves survival rates. Economically, it reduces late-stage treatments, minimizes workforce disruptions, and lowers long-term health spending. Household financial stability would also improve.
Cancer’s Impact on Canada’s Economy and Workforce
Cancer significantly affects Canada’s economy, contributing to lost productivity and rising costs. It supports nearly two million workers and drives innovation, research, and 8% of Canada’s GDP. However, governments often view cancer care as a cost rather than an economic growth opportunity.
